Experimental and clinical studies have shown that FET uptake is highly specific for tumor tissue and is a result of increased LAT1 expression leading to a carrier-mediated facilitated transport in the glioblastoma tissue, and is thus independent of disruption of the BBB [11]. This evidence concerns the gene SLC7A5 and neoplasm.